|
|
|
|
|
|
Home | Recommend | Scoreboard | Previous Picks | Books | Search | Contact Us |
|
On the
first Sunday of each month Stockprowler will bring you his latest hot stock
pick profiled in depth ...free on the Web! And every week Stockprowler
updates the Stockprowler Watch box with exciting new potential momentum
plays. Stockprowler uses state of the art technology to look under the rocks
and find those little stocks with the potential to make the BIG moves.
Stockprowler screens NASDAQ, NYSE, AMEX, and OTC stocks trading under $3.
These stocks offer the speculator considerable leverage. It is not uncommon
for these stocks to make moves of 30%, 50%, or more. Please read our disclaimer before trading
in any stocks mentioned on this Website ... Here's the Stockprowler Report
for the month of July, 2004: |
|
|||||||||||||
|
Stockprowler's pick this week...
Jacobson Resonance Enterprises, Inc. (OTC BB: JRSE) 8200 Jog Rd. Suite 100 Boynton Beach, FL 33437 Phone: (561) 752-4141 Corporate Website: http://www.jrse.com/products.htm Shares Outstanding: 203 million Market Capitalization: $2.1 million Closing Price Friday 0.0112:
Jacobson Resonance Enterprises, Inc. (OTCBB: JRSE) seeks to revolutionize the practice of medicine in the 21st century. Dr. Jerry I. Jacobson, utilizing an electromagnetic resonance principle known as Jacobson Resonance, has developed a proprietary machine having the potential to treat numerous diseases and alleviate suffering. Jacobson’s company has 96 issued, allowed, or pending worldwide patents covering its electromagnetic resonance technology, applications and methodology. JRSE has developed four different models for research and clinical use. Interestingly, the first Jacobson Resonators machines were fabricated at NASA's Stennis Space Center Laboratories. Jacobson Resonance utilizes extremely weak physiologic low frequency electromagnetic fields like those found in the human heart, brain and other organs to beneficially alter molecular characteristics.
The National Chronic Pain Outreach Association (NCPOA) estimates 34 million people in the United States of America suffer chronic pain and because of which approximately 50 million workdays are lost annually. An incredible $100 billion is spent on pain treatment each year in the USA alone. On November 27, 2000 Jacobson received notification of licensing rights from the Therapeutic Products Section of the Canadian Ministry of Health (Health Canada) for commercialization and use of the Jacobson Resonators in Canada. The license indication covers the reduction of pain associated with arthritic conditions. JRSE also received formal license issuance, on January 10, 2001, of the important CE-Mark by the Health Authorities of the European Union in conjunction with the Spanish Health Ministry for medical use, distribution, manufacturing, and sale of Jacobson Resonators throughout the nation members of the European Union. This approval covers the broad spectrum of chronic pain of the knees. On March 1, 2004 JRSE announced that an exclusive line of battery powered portable resonators to alleviate pain and discomfort will be available world-wide, outside the USA, in Q2/Q3, 2004. The first resonator to hit the marketplace will be ‘The Back-Pack’. This miniaturized, lightweight portable device is designed to alleviate pain, discomfort and stiffness in the lower back. It is a durable system that can also be applied to most areas of the body. These resonators will be manufactured in Canada according to ISO standards. The technology being employed has already achieved regulatory licensing clearance in Canada and CE-MARK approval in Europe. P.E.R., Inc. will implement an aggressive worldwide marketing campaign as the resonators will be made available in every continent outside the USA. Sales of these resonators will proceed via the Internet, opt-in-e-mail advertising, followed by print media advertisements in major cities, storefront retail sales where available and eventually infomercials. Dave Davis, Hall of Fame professional bowler and President and CEO of P.E.R., Inc. stated, “We believe that Personal Electromagnetic Resonators, Inc. in association with JRSE brings to the world a state-of- the-art portable resonator that will be unrivaled in its effectiveness to alleviate pain and suffering. P.E. R., Inc., will implement an aggressive worldwide marketing campaign as the resonators will be available around the world.” On April 14, 2004 JRSE released an open letter to stockholders from Harvey Grossman, JRSE President and Chief Operating Officer… Dear Fellow Stockholder; After spending the last five months in Nassau, New Providence, Bahamas with Dr. Jerry I. Jacobson I feel compelled to share with you good news on a few fronts. We are profoundly alleviating the pain and suffering of people on a daily basis, with many of them regaining quality of life. The leasing and selling of Jacobson Resonators worldwide is on the increase and we will be breaking new ground in the healthcare, leisure and spa, beauty and sports arenas.
About fifteen months ago we laid out an action plan to achieve 3 goals in the years 2003/2004. We are well on the way to accomplishing all three of these goals. One was to establish our first self-standing clinical operation outside the USA. Dr. Jacobson has been successfully treating clients at the Magnetic Resonance Therapy Bahamas Limited clinic in the Bahamas Heart Center Expansion, the Centerville Medical Pavilion, a world-class integrated medical facility in Nassau. Clients began paying for services on January 5, 2004 and are arriving from around the world. In a series of upcoming news releases we will include patient testimonials from many who have experienced profound improvements in their quality of life.
The second goal was to prototype highly effective battery powered portable resonators that could be sold worldwide. This phase of development is nearly complete and the ``portables'' will be on sale in the market during quarters 3/4 via our licensee P.E.R., Inc. These highly effective devices have evolved and have been extensively field tested in various forms for five years. The technology used is identical to that being implemented under the regulatory Approvals in Europe, Licensing Clearance in Canada and the FDA allowance to ``enhance feelings of relaxation.''
Our third goal was to enter the Veterinary Medicine Arena. Recent developments lead me to believe that we may enter the Equine area in the coming months. News is forthcoming as it occurs.
A most pleasant and meaningful development occurred when we received an allowance on February 11, 2004 (a submission of Dr. Jacobson's) from FDA Section 513g to “enhance feelings of relaxation'' with Jacobson Resonators. This has created opportunities that we are now considering in depth. We believe that approaching Chiropractors to embrace our technology is a logical objective in the early stages of an evolving business plan.
On June 17, 2004, COO Grossman announced an ”Operating Action Plan'' into the multi-billion dollar Leisure, Beauty and Athletic Fitness arenas with its patented Jacobson Resonators. Grossman stated, “Upon receiving the FDA 513(g) response the company has begun to effectively utilize the Jacobson Resonators ‘to enhance feelings of relaxation’. In pre-market testing, people reported a deeper and more pleasurable sense of relaxation while in the Jacobson Resonator, and also afterwards. We have also organized a ‘United States Operating Action Plan’ prioritizing potential revenue producing arenas that JRSE could enter quickly and effectively. The Leisure, Beauty and Athletic Fitness arenas appear to be the most compatible fit for our current and ‘pipeline’ magnetic resonance technologies that enhance a more effective, deeper and pleasurable state of relaxation.” Action plan goals for Q3/Q4:
Dr. Jerry I. Jacobson stated, “Magnets have been known to produce feelings of relaxation. Thus, from a non-medical point of view, we will be utilizing the Jacobson Resonator ‘to enhance feelings of relaxation’, yet with the kinds of magnetic fields, naturally produced by the body. These fields are actually millions of times weaker than the permanent magnets commonly used. Based upon results in Europe, Canada, and Nassau, the observed effects have been profoundly positive and our approach is natural, safe, and most pleasurable.”
Dr. Jacobson, CEO of JRSE holds a Bachelor of Arts degree in Philosophy from Brooklyn College of the City University of New York and D.D.S. and D.M.D. degrees from Temple University. He served as captain and emergency oral surgeon at Fort Rucker, Alabama, as active service in the Army during the Vietnam conflict. He has also received extensive training in physics after auditing 30 courses at different universities in the New York City and Philadelphia metropolitan areas. Dr. Jacobson was an active dentist and oral surgeon in the New York City area from 1972 to the early 1980's, and was involved in dental research in this period. Dr. Jacobson has also been a student of Albert Einstein's work throughout his life. Since his discovery of the equation of Jacobson Resonance relating to medicine and energy, Dr. Jacobson has focused his research and technology, denoted as Jacobson Resonance, on medical therapy for more than twenty years. His publishing credits include over 100 scientific articles, more than 40 abstracts, three book chapters and two books. He holds six issued and one pending United States patents, for which there are currently patents issued or pending in numerous foreign countries. Dr. Jacobson was made a professor and awarded a PhD in medicine in 2002 by Bundelkhand University, Jhansi, India.
Stockprowler views JRSE (OTC BB) as a highly speculative ground floor opportunity. Shares of JRSE have traded as high as 8 cents in the past 12 months. JRSE has recently traded at or near yearly lows… expect trading to be extremely volatile as word of this company and its potentially revolutionary and lucrative products begins to spread on the OTC BB message boards. Stockprowler does not receive compensation from companies we profile or from third parties... we never have and never will. We use our own money when we buy stocks, and even though we usually take a position in a stock before we profile a company, our purchases are small relative to the public float so that the effect on the stock price when we buy or sell is minimal. Please read our full disclaimer. Also, contrary to a commonly held belief, Stockprowler does not have access to insider information, nor do we want to because trading on insider information is illegal! All information contained in our reports is available in the public record... and any written or verbal communication with company CEOs/IR people strictly adheres to this rule. Readers are urged to read the company SEC filings and do their own due diligence before investing in this or any other stock.
Good Trading... Stockprowler |
|
|
|
Copyright © 2004 Intervast Corp. All rights reserved. | FAQ | Mailbag | Advertise | Disclaimer |